scispace - formally typeset
C

Changyeong Song

Researcher at Seoul National University

Publications -  13
Citations -  3956

Changyeong Song is an academic researcher from Seoul National University. The author has contributed to research in topics: Transdermal & Drug delivery. The author has an hindex of 11, co-authored 13 publications receiving 3057 citations.

Papers
More filters
Journal ArticleDOI

Multifunctional wearable devices for diagnosis and therapy of movement disorders

TL;DR: Materials, mechanics and designs for multifunctional, wearable-on-the-skin systems that address technical challenges via monolithic integration of nanomembranes fabricated with a top-down approach, nanoparticles assembled by bottom-up methods, and stretchable electronics on a tissue-like polymeric substrate are described.
Journal ArticleDOI

Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module.

TL;DR: A wearable/disposable sweat- based glucose monitoring device integrated with a feedback transdermal drug delivery module that provides a novel closed-loop solution for the noninvasive sweat-based management of diabetes mellitus.
Journal ArticleDOI

Continuous O2-Evolving MnFe2O4 Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer

TL;DR: Biocompatible manganese ferrite nanoparticle-anchored mesoporous silica nanoparticles (MFMSNs) are designed to overcome hypoxia, consequently enhancing the therapeutic efficiency of PDT and demonstrating great potential of MFMSNs for theranostic agents in cancer therapy.
Journal ArticleDOI

Stretchable Heater Using Ligand-Exchanged Silver Nanowire Nanocomposite for Wearable Articular Thermotherapy

TL;DR: A soft, thin, and stretchable heater is developed by using a nanocomposite of silver nanowires and a thermoplastic elastomer to create a novel wearable system for long-term, continuous articular thermotherapy.
Journal ArticleDOI

Ceria-Zirconia Nanoparticles as an Enhanced Multi-Antioxidant for Sepsis Treatment.

TL;DR: The obtained Ce0.7 Zr0.3 O2 (7CZ) NPs greatly improve ROS scavenging performance, thus regulating inflammatory cells in a very low dose, and are demonstrated to be effective in reducing mortality and systemic inflammation in two representative sepsis models.